Session Chair Profile

B.S., VP, Agilent Technologies
Biography

Allison Ballmer is VP at Agilent’s Diagnostics and Genomics Group where she is responsible for strategy and corporate development. Allison recently served as International Business Leader at Roche Molecular Systems where she led all aspects of portfolio and strategy to advance Next Generation Sequencing platforms into the clinic. Allison has enjoyed a 15-year career in Cancer Diagnostics, spanning translational medicine to companion diagnostics. She led Global Marketing and Commercialization for the Swiss-based Molecular Diagnostics arm of Biocartis. She held various Business Development and Commercial leadership roles at Roche and began her career at Ventana Medical Systems in Quality, Regulatory and Operations Management. Allison earned her B.S. in Mechanical Engineering from Virginia Tech, and Strategy and Marketing certifications from London Business School and Cornell University. Allison also serves as a Board Director at Mission Bio, a precision medicine single cell genomics company.

Session Abstract – PMWC 2019 Silicon Valley

Session Synopsis: Over the last few years, there has been extraordinary progress in Next-Generation Sequencing and with that we see genetic testing are now increasingly being used for the screening and diagnosis of both cancer and non-cancer conditions. This session will dive into specifics around cancer testing, where it is headed, applications, concerns, and opportunities.

Don't Miss Important Precision Medicine Updates

PMWC is the most comprehensive precision medicine conference. To receive the lastest news and updates from the field, subscribe to the newsletter here.

You have Successfully Subscribed!